Forward Science launches liquid cytology test
February 28, 2014 -- Forward Science Technologies, manufacturer of the oral cancer screening device OralID, has released CytID, a liquid-based cytology method for sampling tissue highlighted by OralID.
Study: Limited radiation to salivary glands is safe for HNC
February 20, 2014 -- Avoiding the contralateral submandibular gland during radiation therapy is feasible and safe with advanced stage, node-positive head and neck cancers and base of tongue lesions, and can decrease the side effect of dry mouth for patients, according to a study presented February 20 at the Multidisciplinary Head and Neck Cancer Symposium.
Cancer stem cell types predict outcome of HPV-related HNC
February 10, 2014 -- The type of cancer stem cells, rather than the number, is a better predictor of the survival of patients with human papillomavirus (HPV)-related head and neck cancers (HNCs), according to a new study in Cancer. Previously, researchers thought patients with HPV-positive tumors had better outcomes because their tumors had fewer cancer stem cells than HPV-negative ones.
AADR praises CVS for ceasing tobacco sales
February 7, 2014 -- The American Association for Dental Research (AADR) is applauding CVS for being the first national pharmacy chain to cease the sale of tobacco in its stores.
FDA launches youth tobacco prevention campaign
February 6, 2014 -- The U.S. Food and Drug Administration (FDA) is launching a national public education campaign targeting at-risk youths ages 12 to 17 with "real cost" messages about the consequences of tobacco use.
Aspirin can help battle head/neck cancer
Aspirin appears to offer significant protection against head and neck (HNC) cancer, according to a study in the British Journal of Cancer. Regular aspirin use was associated with a 22% reduction in HNC and seems to be particularly effective in preventing laryngeal cancer.